Patents Assigned to ANJARIUM BIOSCIENCES AG
  • Hybridosomes, compositions comprising the same, processes for their production and uses thereof
    Patent number: 11944706
    Abstract: The present invention provides a hybrid biocompatible carrier (hybridosome) which comprises structural and bioactive elements originating from at least one biocompatible delivery module (BDM) and at least one engineered drug encapsulation module (EDEM) comprising at least one tunable fusogenic moiety. The invention further provides pharmaceutical compositions comprising said hybridosomes, processes for their manufacture, as well as pharmaceutical uses and pharmaceutical methods based thereon.
    Type: Grant
    Filed: September 12, 2022
    Date of Patent: April 2, 2024
    Assignee: Anjarium Biosciences AG
    Inventor: Joel de Beer
  • Compositions of DNA Molecules, Methods of Making Therefor, and Methods of Use Thereof
    Publication number: 20230323418
    Abstract: Provided herein are double strand DNA molecules comprising inverted repeats, expression cassette and one or more restriction sites for nicking endonucleases, the methods of use thereof, and the methods of making therefor.
    Type: Application
    Filed: November 18, 2022
    Publication date: October 12, 2023
    Applicant: Anjarium Biosciences AG
    Inventors: Joel de Beer, Monique Maurer, Nicolas Meier, Lavaniya Kunalingam, Marcello Clerici
  • HYBRIDOSOMES, COMPOSITIONS COMPRISING THE SAME, PROCESSES FOR THEIR PRODUCTION AND USES THEREOF
    Publication number: 20230181467
    Abstract: The present invention provides a hybrid biocompatible carrier (hybridosome) which comprises structural and bioactive elements originating from at least one biocompatible delivery module (BDM) and at least one engineered drug encapsulation module (EDEM) comprising at least one tunable fusogenic moiety. The invention further provides pharmaceutical compositions comprising said hybridosomes, processes for their manufacture, as well as pharmaceutical uses and pharmaceutical methods based thereon.
    Type: Application
    Filed: September 12, 2022
    Publication date: June 15, 2023
    Applicant: ANJARIUM BIOSCIENCES AG
    Inventor: Joel de Beer
  • Compositions of DNA molecules, methods of making therefor, and methods of use thereof
    Patent number: 11634742
    Abstract: Provided herein are double strand DNA molecules comprising inverted repeats, expression cassette and one or more restriction sites for nicking endonucleases, the methods of use thereof, and the methods of making therefor.
    Type: Grant
    Filed: August 17, 2021
    Date of Patent: April 25, 2023
    Assignee: Anjarium Biosciences AG
    Inventors: Joel de Beer, Monique Maurer, Nicolas Meier, Lavaniya Kunalingam, Marcello Clerici
  • Hybridosomes, compositions comprising the same, processes for their production and uses thereof
    Patent number: 11484500
    Abstract: The present invention provides a hybrid biocompatible carrier (hybridosome) which comprises structural and bioactive elements originating from at least one biocompatible delivery module (BDM) and at least one engineered drug encapsulation module (EDEM) comprising at least one tunable fusogenic moiety. The invention further provides pharmaceutical compositions comprising said hybridosomes, processes for their manufacture, as well as pharmaceutical uses and pharmaceutical methods based thereon.
    Type: Grant
    Filed: January 2, 2020
    Date of Patent: November 1, 2022
    Assignee: ANJARIUM BIOSCIENCES AG
    Inventor: Joel De Beer
  • Compositions of DNA Molecules, Methods of Making Therefor, and Methods of Use Thereof
    Publication number: 20220098633
    Abstract: Provided herein are double strand DNA molecules comprising inverted repeats, expression cassette and one or more restriction sites for nicking endonucleases, the methods of use thereof, and the methods of making therefor.
    Type: Application
    Filed: August 17, 2021
    Publication date: March 31, 2022
    Applicant: Anjarium Biosciences AG
    Inventors: Joel de Beer, Monique Maurer, Nicolas Meier, Lavaniya Kunalingam, Marcello Clerici
  • HYBRIDOSOMES, COMPOSITIONS COMPRISING THE SAME, PROCESSES FOR THEIR PRODUCTION AND USES THEREOF
    Publication number: 20200222324
    Abstract: The present invention provides a hybrid biocompatible carrier (hybridosome) which comprises structural and bioactive elements originating from at least one biocompatible delivery module (BDM) and at least one engineered drug encapsulation module (EDEM) comprising at least one tunable fusogenic moiety. The invention further provides pharmaceutical compositions comprising said hybridosomes, processes for their manufacture, as well as pharmaceutical uses and pharmaceutical methods based thereon.
    Type: Application
    Filed: January 2, 2020
    Publication date: July 16, 2020
    Applicant: ANJARIUM BIOSCIENCES AG
    Inventor: Joel DE BEER
  • Hybridosomes, compositions comprising the same, processes for their production and uses thereof
    Patent number: 10561610
    Abstract: The present invention provides a hybrid biocompatible carrier (hybridosome) which comprises structural and bioactive elements originating from at least one biocompatible delivery module (BDM) and at least one engineered drug encapsulation module (EDEM) comprising at least one tunable fusogenic moiety. The invention further provides pharmaceutical compositions comprising said hybridosomes, processes for their manufacture, as well as pharmaceutical uses and pharmaceutical methods based thereon.
    Type: Grant
    Filed: January 20, 2015
    Date of Patent: February 18, 2020
    Assignee: ANJARIUM BIOSCIENCES AG
    Inventor: Joel De Beer
  • HYBRIDOSOMES, COMPOSITIONS COMPRISING THE SAME, PROCESSES FOR THEIR PRODUCTION AND USES THEREOF
    Publication number: 20160354313
    Abstract: The present invention provides a hybrid biocompatible carrier (hybridosome) which comprises structural and bioactive elements originating from at least one biocompatible delivery module (BDM) and at least one engineered drug encapsulation module (EDEM) comprising at least one tunable fusogenic moiety. The invention further provides pharmaceutical compositions comprising said hybridosomes, processes for their manufacture, as well as pharmaceutical uses and pharmaceutical methods based thereon.
    Type: Application
    Filed: January 20, 2015
    Publication date: December 8, 2016
    Applicant: ANJARIUM BIOSCIENCES AG
    Inventor: Joel DE BEER